Related references
Note: Only part of the references are listed.SH3GL3 functions as a potent tumor suppressor in lung cancer in a SH3 domain dependent manner
Zhongkun Lin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Adaptor protein LNK promotes anaplastic thyroid carcinoma cell growth via 14-3-3 ε/γ binding
Zhao-Ming Zhong et al.
CANCER CELL INTERNATIONAL (2020)
LNK promotes the growth and metastasis of triple negative breast cancer via activating JAK/STAT3 and ERK1/2 pathway
Jianxin Lv et al.
CANCER CELL INTERNATIONAL (2020)
STAT1 determines aggressiveness of glioblastoma both in vivo and in vitro through wnt/β-catenin signalling pathway
Li Zhao et al.
CELL BIOCHEMISTRY AND FUNCTION (2020)
SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain
Paul B. Sinclair et al.
LEUKEMIA (2019)
Activation of STAT1 by the FRK tyrosine kinase is associated with human glioma growth
Lei Hua et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide
Sang-Soo Kim et al.
NUCLEIC ACIDS RESEARCH (2018)
Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells
Jianghong Man et al.
CELL STEM CELL (2018)
Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells
Yu Shi et al.
CELL DEATH AND DIFFERENTIATION (2017)
LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway
Yiwei Liao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders
N. Maslah et al.
LEUKEMIA (2017)
Targeted sequencing of established and candidate colorectal cancer genes in the Colon Cancer Family Registry Cohort
Leon Raskin et al.
ONCOTARGET (2017)
Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide
Hongwei Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis
Wei Wang et al.
CIRCULATION RESEARCH (2016)
The function of SH2B3 (LNK) in the kidney
Gregory Blass et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency
Hongwei Chen et al.
NATURE COMMUNICATIONS (2015)
LNK (SH2B3): paradoxical effects in ovarian cancer
L-W Ding et al.
ONCOGENE (2015)
The Somatic Genomic Landscape of Glioblastoma (Vol 155, pg 462, 2013)
Cameron W. Brennan et al.
CELL (2014)
Genetic loss of SH2B3 in acute lymphoblastic leukemia
Arianne Perez-Garcia et al.
BLOOD (2013)
An objective clustering of GBM patients to identify clinically relevant subgroup with Hedgehog pathway activity
Tapojyoti Das et al.
CANCER RESEARCH (2013)
Role of the adaptor protein LNK in normal and malignant hematopoiesis
S. Gery et al.
ONCOGENE (2013)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan et al.
NATURE (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
G-Cimp Status Prediction Of Glioblastoma Samples Using mRNA Expression Data
Mehmet Baysan et al.
PLOS ONE (2012)
The adaptor Lnk (SH2B3): An emerging regulator in vascular cells and a link between immune and inflammatory signaling
Julie Devalliere et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Nonreceptor Tyrosine Kinase BMX Maintains Self-Renewal and Tumorigenic Potential of Glioblastoma Stem Cells by Activating STAT3
Olga A. Guryanova et al.
CANCER CELL (2011)
Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin G. Van Meir et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
Mutation of the inhibitory adaptor protein LNK drives potentiated JAK-STAT signaling in patients with JAK2 V617F-negative myeloproliferative neoplasms
Stephen T. Oh et al.
CANCER RESEARCH (2010)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
The Lnk adaptor protein negatively regulates specific SCF biological responses in primary hematopoietic cells
Clotilde Simon et al.
CYTOKINE (2008)
Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction
Jun Seita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
